Serogroup B Meningococcal Disease

Slides:

Advertisements

Similar presentations

Contents  Describe epidemiology of meningococcal serogroups C disease  What, why and when are the changes happening  Which vaccines are recommended?

Advertisements

An Approach to Demonstration of Effectiveness

Surveillance report Annual Epidemiological Report on communicable diseases in Europe ECDC Surveillance Unit European Centre for Disease Prevention and.

Adult Immunization 2010 Meningococcal Vaccine Segment This material is in the public domain This information is valid as of May 25, 2010.

Infectious Disease Modelling: challenges for policy makers Dr Mary Ramsay Head of Immunisation Public Health England.

Case study: infectious disease Professor Anne Johnson FMedSci Head, Department of Primary Care and Population Sciences, Royal Free and University College.

Introduction for Basic Epidemiological Analysis for Surveillance Data National Center for Immunization & Respiratory Diseases Influenza Division.

1 Approaches to Demonstrate Effectiveness of Vaccines for Prevention of Group B Meningococcal Disease Introduction Vaccines and Related Biological Products.

Influenza H1N1 Introduction. What is Influenza A H1N1?  Influenza virus  Family Orthomyxoviridae  2 important surface proteins  Haemagglutinin (H)

Chapter 28 Meningococcal Disease. Epidemiology – U.S. Each year 1,400-3,000 cases of meningococcal disease (MD) in the US per 100,000 population.

What is meningococcal disease?  Adolescents and young adults are at increased risk of meningococcal disease, often referred to as meningitis, a serious.

Meningococcal Vaccination

Session 3: Molecular Epidemiology Introduction

Contents - HIV global slides

MenACWY – new immunisation programme? What’s new?

Nicki Banyard South London Health Protection Team

The changing epidemiology of invasive meningococcal disease in Australia: continuing rise in meningococcal W disease Julia Maguire Master of Philosophy.

Annual Epidemiological Report on communicable diseases in Europe

Sexually Transmitted Infections in Europe, 2012

Table 1. Cases of reported, confirmed cases of invasive meningococcal disease: number and rate per population, EU/EEA, 2010–2014 Country

Figure 1. Number of reported hantavirus infection cases, EU/EEA, 2014

Influenza Immunization:

Back to School 2013: An Immunization Checklist

CDK 4 and 6 Inhibitors in HR-Positive Breast Cancer: Implementing Paradigms in Clinical Practice.

An Update on Meningococcal Disease Dr Suzanne Cotter

Dengue Prevention in Asia

Characteristics of pathogenic Neisseria meningitidis in Moscow: prevalence of ‘non- European’ strains Irina S. Koroleva, Alexander E. Platonov, Arie van.

KEY CONCEPT Some viral diseases can be prevented with vaccines.

WHO HIV update July 2018 Global epidemic Global progress and cascade

Incidence of notified cases of hepatitis B in Italy. SEIEVA

Meningococcal Disease: Optimizing Protection in Adolescents

Table 1. Number and rate of reported confirmed syphilis cases per 100 000 population by country and year, EU/EEA, 2010–2014 Country

HPV-Related Disease: Separating Fact From Fiction

Global Update on Varicella: Protecting Against an Old Enemy

DENGUE VACCINE.

Meningococcal disease/vaccination update Ray Borrow

Contents - HIV global slides

Immunizing the Older Adult: Challenges and Opportunities

ACIP Recommended Vaccines for Adults – By Age

Immunization Against Varicella:

The State of Pneumococcal Disease Prevention

Meningococcal Meningitis

A Case-based Approach to RSV Disease

Maternal Pertussis vaccination: Giving Newborns a head start

Meningococcal B Vaccination Implementing the ACIP Category B Recommendations.

Leaving no-one behind UNAIDS.

World Health Organization

Preventing HPV-related Disease: What Do the Latest Data Tell Us?

AIDS-related deaths the lowest this century

Preventing Meningococcal B Disease

Epidemiology of Meningococcal disease in Scotland

IBD Increases Risk for Vaccine-Preventable Diseases

Contents - HIV global slides

Immunization Throughout the Life Course: What Is the Clinician's Role?

Meningococcal carriage in Dutch adolescents and young adults; a cross-sectional and longitudinal cohort study M.B. van Ravenhorst, M.W. Bijlsma, M.A.

Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study

Prioritizing Prevention of HPV-Related Disease

Contents - HIV global slides

Strategies for Infection Control in Cystic Fibrosis

Trends for ECDC measles and rubella monitoring,

KEY CONCEPT Some viral diseases can be prevented with vaccines.

Contribution of individual serovars within serogroups isolated in the United States in Contribution of individual serovars within serogroups isolated.

Emerging Models of Protection

A decade of Latin-American experience with HPV prevention

KEY CONCEPT Some viral diseases can be prevented with vaccines.

Contribution of Vaccines to Life-Course Event-Free Health

Bacterial/Viral Meningitis & Haemophilus influenzae Trends in Ireland

KEY CONCEPT Some viral diseases can be prevented with vaccines.

MenB Update: Communicating the Imperative With Parents

Trends in Hepatitis B Vaccine Coverage and Acute Hepatitis B Incidence among Adolescents in California Elisha Larez and Celia Woodfill California Department.

Presentation transcript:

Serogroup B Meningococcal Disease

Program Overview

N. meningitidis and IMD

Meningococcal Serogroups: Global Distribution

Incidence of MenB Disease

Greater Heterogeneity Among Serogroup B Isolates

MenB Outbreaks: Frequent and Prolonged

Key Messages

MenB Infection and Prevention in the Czech Republic

Serogroup Distribution and Incidence of IMD

Clonal Complexes of N. meningitidis From IMD

Age-Specific Incidence of IMD: Surveillance Data

Coverage of Czech N meningitidis Isolates in 4CMenB Vaccine

Conclusion

MenB Infection and Prevention in Italy

Incidence of IMD, 2000-2016

IMD by Serogroup, 2011-2016

Incidence of IMD by Age Group in Italy

MenB Vaccination: National Immunization Plan Since 2017

Conclusion

MenB Infection and Prevention in the United Kingdom

UK National Immunization Plan for MenB

Uptake of 4CMenB

Rapid Decline in MenB Disease Since Implementation

Other Progress With MenB Since Implementation

Key Messages

Closing Remarks

Key Messages

Abbreviations

Abbreviations (cont)